{"id":3803,"date":"2018-01-29T17:49:52","date_gmt":"2018-01-29T22:49:52","guid":{"rendered":"http:\/\/www.ipoboutique.com\/blog\/?p=3803"},"modified":"2018-01-29T17:51:40","modified_gmt":"2018-01-29T22:51:40","slug":"secondaries-announced-1-29-18","status":"publish","type":"post","link":"https:\/\/www.ipoboutique.com\/blog\/secondaries-announced-1-29-18\/","title":{"rendered":"Secondaries Announced 1.29.18"},"content":{"rendered":"

IPO BOUTIQUE CLIENTS\u00a0and\u00a0IPO BOUTIQUE SECONDARY ALERTS CLIENTS\u00a0received ALL this information to their inbox on a\u00a0REAL TIME\u00a0basis.<\/strong><\/h4>\n

If having\u00a0real-time alerts for secondary offerings<\/strong><\/a>\u00a0would be an advantage to you,\u00a0inquire about a subscription today!<\/a><\/p>\n

Our Buy, Neutral or Avoid ratings of the Secondaries below are intended as a recommendation for those who buy Secondaries on a regular basis. For example, this is not to be interpreted as a Buy recommendation in the traditional sense of adding to your stock portfolio; this is a short term (usually one day or opening trade) time period.
\nCompany: Fusion
\nSymbol: FSNN
\nPrice: Last Trade $3.59
\nTrade Date: 2\/1
\nShares: 8.4 million ($30m cash raise)
\nUnderwriter(s): Craig Hallum
\nCo-Manager: B.Riley FBR
\nDescription: They are a leading provider of cloud services.
\nRating = Subscription Needed<\/a><\/strong><\/p>\n

Company: Amarin Corporation plc
\nSymbol: AMRN
\nPrice: Last Trade $4.01
\nTrade Date: 1\/30
\nShares: 17.5 million ($70m cash raise)
\nRe-Offer Range: Subscription Needed<\/a><\/strong>
\nUnderwriter(s): Cantor Fitzgerald & Co.
\nDescription: They are a biopharmaceutical company focused on the commercialization and development of therapeutics to improve cardiovascular health.
\nRating =\u00a0Subscription Needed<\/a><\/strong><\/p>\n

\"Screen<\/a><\/p>\n

Company: Ultra Clean Holdings, Inc.
\nSymbol: UCTT
\nPrice: Last Trade $23.04
\nTrade Date: 1\/31
\nShares: 4.4 million ($100m cash raise)<\/p>\n

Underwriter(s): Needham & Co., Cowen
\nCo-Manager(s): Craig Hallum
\nDescription: They are a leading developer and supplier of critical systems and subsystems for the semiconductor capital equipment, flat panel, medical, energy and research industries.
\nRating = Subscription Needed<\/a><\/strong><\/p>\n

Company: Sun Hydraulics Corporation
\nSymbol: SNHY
\nPrice: Last Trade $69.19
\nTrade Date: 2\/2
\nShares: 4 million
\nUnderwriter(s): Morgan Stanley
\nCo-Manager(s): KeyBanc Capital, Oppenheimer & Co., Stifel, SunTrust Robinson Humphrey, William Blair
\nDescription: Sun Hydraulics Corporation is an industrial technology leader that develops and manufactures solutions for both the hydraulics and electronics markets.
\nRating = Subscription Needed<\/a><\/strong><\/p>\n

Company: Clementia Pharmaceuticals – Block
\nSymbol: CMTA
\nPrice: Last Trade $18.21
\nTrade Date: 1\/30
\nShares: 0.78 million
\nRe-Offer Range: Subscription Needed<\/a><\/strong>
\nUnderwriter(s): Morgan Stanley
\nDescription:Clementia Pharmaceuticals Inc., a clinical stage biopharmaceutical company, develops disease-modifying treatments for patients suffering from debilitating bone and other diseases.
\nRating = Subscription Needed<\/a><\/strong><\/p>\n

Company: SandRidge Energy, Inc. – Block
\nSymbol: SD
\nPrice: Last Trade $19.55
\nTrade Date: 1\/30
\nShares: 1.9 million
\nRe-Offer Range: Subscription Needed<\/a><\/strong>
\nUnderwriter(s): Morgan Stanley
\nDescription: They are an oil and natural gas company, engages in the exploration, development, and production of oil, natural gas, and natural gas liquids primarily in the Mid-Continent and Rockies regions of the United States.
\nRating = Subscription Needed<\/a><\/strong><\/p>\n

Company: CymaBay Therapeutics, Inc.
\nSymbol: CBAY
\nPrice: Last Trade $11.29
\nTrade Date: 1\/30
\nShares: 9.2 million ($100 million cash raise)
\nRe-Offer Range: Subscription Needed<\/a><\/strong>
\nUnderwriter(s): Leerink, Evercore ISI
\nDescription: They are a clinical-stage biopharmaceutical company focused on developing therapies for liver and other chronic diseases with high unmet medical need.
\nRating = Subscription Needed<\/a><\/strong><\/p>\n","protected":false},"excerpt":{"rendered":"

IPO BOUTIQUE CLIENTS\u00a0and\u00a0IPO BOUTIQUE SECONDARY ALERTS CLIENTS\u00a0received ALL this information to their inbox on a\u00a0REAL TIME\u00a0basis. If having\u00a0real-time alerts for secondary offerings\u00a0would be an advantage to you,\u00a0inquire about a subscription today! Our Buy, Neutral or Avoid ratings of the Secondaries below are intended as a recommendation for those who buy Secondaries on a regular basis.[…]<\/p>\n","protected":false},"author":2,"featured_media":0,"comment_status":"closed","ping_status":"closed","sticky":false,"template":"","format":"standard","meta":{"zakra_general_container_width":0,"zakra_general_content_width":0,"zakra_general_sidebar_width":0,"zakra_sticky_header":"customizer","zakra_header_main_area":true,"zakra_site_logo_width":0,"zakra_header_top_enabled":"customizer","zakra_header_top_style":"customizer","zakra_primary_menu_item_style":"customizer","zakra_page_header_text_color":"","zakra_page_header_layout":"customizer","zakra_page_title_bg":"","zakra_footer_widgets_bg_image":0,"zakra_page_title_bg_repeat":"customizer","zakra_page_title_bg_position":"customizer","zakra_page_title_bg_size":"customizer","zakra_page_title_bg_attachment":"customizer","zakra_breadcrumbs_enabled":"customizer","zakra_breadcrumbs_text_color":"","zakra_breadcrumbs_separator_color":"","zakra_breadcrumbs_link_color":"","zakra_breadcrumbs_link_hover_color":"","zakra_page_title_bg_image":0,"zakra_footer_widgets_enabled":"customizer","zakra_footer_column_layout_1_style":"customizer","zakra_footer_widgets_bg":"","zakra_footer_widgets_bg_repeat":"customizer","zakra_footer_widgets_bg_position":"customizer","zakra_footer_widgets_bg_size":"customizer","zakra_footer_widgets_bg_attachment":"customizer","zakra_footer_bar_enabled":"customizer","zakra_footer_bar_style":"customizer","footnotes":""},"categories":[35],"tags":[],"class_list":["post-3803","post","type-post","status-publish","format-standard","hentry","category-secondary-offerings"],"_links":{"self":[{"href":"https:\/\/www.ipoboutique.com\/blog\/wp-json\/wp\/v2\/posts\/3803","targetHints":{"allow":["GET"]}}],"collection":[{"href":"https:\/\/www.ipoboutique.com\/blog\/wp-json\/wp\/v2\/posts"}],"about":[{"href":"https:\/\/www.ipoboutique.com\/blog\/wp-json\/wp\/v2\/types\/post"}],"author":[{"embeddable":true,"href":"https:\/\/www.ipoboutique.com\/blog\/wp-json\/wp\/v2\/users\/2"}],"replies":[{"embeddable":true,"href":"https:\/\/www.ipoboutique.com\/blog\/wp-json\/wp\/v2\/comments?post=3803"}],"version-history":[{"count":3,"href":"https:\/\/www.ipoboutique.com\/blog\/wp-json\/wp\/v2\/posts\/3803\/revisions"}],"predecessor-version":[{"id":3807,"href":"https:\/\/www.ipoboutique.com\/blog\/wp-json\/wp\/v2\/posts\/3803\/revisions\/3807"}],"wp:attachment":[{"href":"https:\/\/www.ipoboutique.com\/blog\/wp-json\/wp\/v2\/media?parent=3803"}],"wp:term":[{"taxonomy":"category","embeddable":true,"href":"https:\/\/www.ipoboutique.com\/blog\/wp-json\/wp\/v2\/categories?post=3803"},{"taxonomy":"post_tag","embeddable":true,"href":"https:\/\/www.ipoboutique.com\/blog\/wp-json\/wp\/v2\/tags?post=3803"}],"curies":[{"name":"wp","href":"https:\/\/api.w.org\/{rel}","templated":true}]}}